168 related articles for article (PubMed ID: 37377100)
1. N-acetylcysteine improves autism-like behavior by recovering autophagic deficiency and decreasing Notch-1/Hes-1 pathway activity.
Zhang YH; Wang T; Li YF; Deng YN; He XL; Wang LJ
Exp Biol Med (Maywood); 2023 Jun; 248(11):966-978. PubMed ID: 37377100
[TBL] [Abstract][Full Text] [Related]
2. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine ameliorates repetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism.
Zhang Y; Cui W; Zhai Q; Zhang T; Wen X
Mol Med Rep; 2017 Aug; 16(2):2233-2240. PubMed ID: 28627665
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism.
Adıgüzel E; Çiçek B; Ünal G; Aydın MF; Barlak-Keti D
Physiol Behav; 2022 Nov; 256():113961. PubMed ID: 36100109
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
7. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
9. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
10. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
Baronio D; Castro K; Gonchoroski T; de Melo GM; Nunes GD; Bambini-Junior V; Gottfried C; Riesgo R
PLoS One; 2015; 10(1):e0116363. PubMed ID: 25560049
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
[TBL] [Abstract][Full Text] [Related]
12. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
[TBL] [Abstract][Full Text] [Related]
13. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway.
Elesawy RO; El-Deeb OS; Eltokhy AK; Arakeep HM; Ali DA; Elkholy SS; Kabel AM
Biomed Pharmacother; 2022 Jun; 150():112960. PubMed ID: 35447549
[TBL] [Abstract][Full Text] [Related]
14. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
[TBL] [Abstract][Full Text] [Related]
15. The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism.
Deng Y; Ma L; Du Z; Ma H; Xia Y; Ping L; Chen Z; Zhang Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr; 131():110947. PubMed ID: 38242426
[TBL] [Abstract][Full Text] [Related]
16. Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder.
Shahrbabaki SSV; Moslemizadeh A; Amiresmaili S; Tezerji SS; Juybari KB; Sepehri G; Shamsi Meymandi M; Bashiri H
Neurotoxicology; 2023 May; 96():154-165. PubMed ID: 36933665
[TBL] [Abstract][Full Text] [Related]
17. The GABAB receptor agonist STX209 reverses the autism‑like behaviour in an animal model of autism induced by prenatal exposure to valproic acid.
Jiang S; Xiao L; Sun Y; He M; Gao C; Zhu C; Chang H; Ding J; Li W; Wang Y; Sun T; Wang F
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244195
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled estrogen receptor (GPER) selective agonist G1 attenuates the neurobehavioral, molecular and biochemical alterations induced in a valproic acid rat model of autism.
Hameed RA; Ahmed EK; Mahmoud AA; Atef AA
Life Sci; 2023 Sep; 328():121860. PubMed ID: 37331505
[TBL] [Abstract][Full Text] [Related]
19. The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism.
Lima-Castañeda LÁ; Bringas ME; Aguilar-Hernandez L; Garcés-Ramírez L; Morales-Medina JC; Flores G
J Chem Neuroanat; 2023 Oct; 132():102317. PubMed ID: 37482145
[TBL] [Abstract][Full Text] [Related]
20. Music alleviates cognitive impairments in an animal model of autism.
Taheri F; Joushi S; Esmaeilpour K; Sheibani V; Ebrahimi MN; Taheri Zadeh Z
Int J Dev Neurosci; 2023 Aug; 83(5):399-416. PubMed ID: 37246451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
